Document:

Exhibit 4.1

 

THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED
UNLESS (I) A REGISTRATION STATEMENT REGISTERING SUCH SECURITIES UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS SHALL
HAVE BECOME EFFECTIVE, OR (II) AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND OR QUALIFICATION UNDER APPLICABLE STATE
SECURITIES LAWS IS AVAILABLE IN CONNECTION WITH SUCH OFFER, SALE OR TRANSFER.

 

AN INVESTMENT IN THESE SECURITIES INVOLVES
A HIGH DEGREE OF RISK. HOLDERS MUST RELY ON THEIR OWN ANALYSIS OF THE INVESTMENT AND ASSESSMENT OF THE RISKS INVOLVED.

 

	Warrant to Purchase	 
	 ___________ shares	2014 Series Secured Note Warrant Number - ____ 

 

Warrant to Purchase Common Stock

of

CRYOPORT, INC.

 

THIS CERTIFIES that ____________ or any
subsequent holder hereof (“Holder”) has the right to purchase from Cryoport, Inc., a Nevada corporation, (the “Company”),
________ (______) fully paid and nonassessable shares of the Company’s common stock, $0.001 par value per share (“Common
Stock”), subject to adjustment as provided herein, at a price equal to the Exercise Price as defined in Section 3 below at
any time during the Exercise Period (as defined below).

 

Holder agrees with the Company that this
Warrant to Purchase Common Stock of the Company (this “Warrant” or this “Agreement”) is issued and all
rights hereunder shall be held subject to all of the conditions, limitations and provisions set forth herein.

 

1. Term and Restriction
on Exercise.

 

This Warrant may not be exercised until
May 31, 2015 and the rights under this Warrant expire at 5:00 p.m., Pacific Time, on November 30, 2021 (such period of exercise
is referred to herein as the “Term”).

 

Notwithstanding anything herein to the
contrary, the Company shall not issue to the Holder, and the Holder may not acquire, a number of shares of Common Stock upon exercise
of this Warrant to the extent that, upon such exercise, the number of shares of Common Stock then beneficially owned by the Holder
and its Affiliates and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with the Holder’s
for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (including
shares held by any “group” of which the Holder is a member, but excluding shares beneficially owned by virtue of the
ownership of securities or rights to acquire securities that have limitations on the right to convert, exercise or purchase similar
to the limitation set forth herein) would exceed 9.98% of the total number of shares of Common Stock then issued and outstanding
(the “9.98% Cap”), provided that the 9.98% Cap shall only apply to the extent that the Common Stock is deemed to constitute
an “equity security” pursuant to Rule 13d-1(i) promulgated under the Exchange Act. For purposes hereof, “group”
has the meaning set forth in Section 13(d) of the Exchange Act and applicable regulations of the Securities and Exchange Commission
(the “SEC”), and the percentage held by the Holder shall be determined in a manner consistent with the provisions of
Section 13(d) of the Exchange Act. Upon the written request of the Holder, the Company shall, within two (2) Trading Days,
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.

 

    	1

    	 

    

 

“Affiliate” means any person
or entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a person or entity, as such terms are used in and construed under Rule 144 under the Securities Act of 1933, as amended (the
“Securities Act”). With respect to a Holder of Warrants, any investment fund or managed account that is managed on
a discretionary basis by the same investment manager as such Holder will be deemed to be an Affiliate of such Holder.

 

2. Exercise.

 

(a) Manner of Exercise.
During the Term (the “Exercise Period”), this Warrant may be Exercised as to all or any lesser number of whole shares
of Common Stock covered hereby (the “Warrant Shares” or the “Shares”) upon surrender of this Warrant, with
the Exercise Form attached hereto as Exhibit A (the “Exercise Form”) duly completed and executed, together
with the full Exercise Price (as defined below, which may be satisfied by a Cash Exercise or a Cashless Exercise, each as defined
below) for each share of Common Stock as to which this Warrant is Exercised, at the office of the Company, Cryoport, Inc., 20382
Barrents Sea Circle, Lake Forest, California 92630; Fax: (949) 470-2306, with an electronic copy (for informational purposes only,
and not constituting delivery hereunder) to: stockadministrator@cryoport.com, or at such other office or agency as the Company
may designate in writing, by overnight mail, with an advance copy of the Exercise Form sent to the Company by facsimile (such surrender
and payment of the Exercise Price hereinafter called the “Exercise” of this Warrant).

 

(b) Date of Exercise.
If any portion of the Exercise Price is satisfied by a Cash Exercise (as defined below), the “Date of Exercise” of
the Warrant shall be defined as the later of (A) the date that the Exercise Form attached hereto as Exhibit A, completed
and executed, is sent by facsimile or email to the Company, provided that the original Warrant and Exercise Form are received by
the Company, each as soon as practicable thereafter (or, the date the original Exercise Form is received by the Company, if Holder
has not sent advance notice by facsimile) and (B) the date that the Exercise Price is received by the Company. If no portion of
the Exercise Price is satisfied by a Cash Exercise, the “Date of Exercise” of the Warrant shall be defined as the date
that the Exercise Form attached hereto as Exhibit A, completed and executed, is sent by facsimile or email to the Company,
provided that the original Warrant and Exercise Form are received by the Company, each as soon as practicable thereafter (or, the
date the original Exercise Form is received by the Company, if Holder has not sent advance notice by facsimile or email).

 

(c)
Delivery of Common Stock Upon Exercise. Within three (3) business days after any Date of Exercise, or in the case of a Cashless
Major Exercise as defined in Section 5(c) below, within the period provided in Section 5(c)(iv) (the “Delivery Period”),
the Company shall issue and deliver (or cause its Transfer Agent to issue and deliver) in accordance with the terms hereof to
or upon the order of the Holder that number of shares of Common Stock (“Exercise Shares”) for the portion of this
Warrant exercised as shall be determined in accordance herewith. Upon the Exercise of this Warrant or any part hereof, the Company
shall, at its own cost and expense, take all necessary action, including obtaining and delivering an opinion of counsel, to assure
that the Transfer Agent shall issue stock certificates in the name of Holder (or its nominee) or such other persons as designated
by Holder and in such denominations to be specified at Exercise representing the number of shares of Common Stock issuable upon
such Exercise.

 

(d) Delivery Failure.
In addition to any other remedies which may be available to the Holder, in the event that the Company fails for any reason to effect
delivery of the Exercise Shares by the end of the Delivery Period (a “Delivery Failure”), the Holder will be entitled
to revoke all or part of the relevant Exercise Form by delivery of a notice to such effect to the Company via facsimile or email
not later than three (3) Trading Days after the end of the Delivery Period, whereupon the Company and the Holder shall each be
restored to their respective positions immediately prior to the delivery of such notice, except that the liquidated damages described
herein shall be payable through the date notice of revocation or rescission is given to the Company.

 

(e) Restrictive Legend.
The Holder understands that the Exercise Shares will be issued pursuant to a claimed exemption from registration under the Securities
Act and thus the certificate for the Exercise Shares will bear a restrictive legend in substantially the following form (and a
stop-transfer order will be placed against transfer of the certificates for such securities):

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
THE SECURITIES MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING,
WITHOUT LIMITATION, PURSUANT TO RULES 144 OR 144A UNDER SAID ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER APPLICABLE FORMAL
OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED “4(1) AND A HALF” SALE.”

 

    	 

    	 

    

 

(f) Cancellation of
Warrant. This Warrant shall be canceled upon the full Exercise of this Warrant and if this Warrant is not Exercised in full,
Holder shall be entitled to receive a new Warrant (containing terms identical to this Warrant) representing any unexercised portion
of this Warrant in addition to such Common Stock.

 

(g) Holder of Record.
Each person in whose name any Warrant for shares of Common Stock is issued shall, for all purposes, be deemed to be the Holder
of record of such shares on the Date of Exercise of this Warrant, irrespective of the date of delivery of the Common Stock purchased
upon the Exercise of this Warrant.

 

3. Payment of Warrant
Exercise Price for Cash Exercise or Cashless Exercise; Cashless Major Exercise.

 

(a) Exercise Price.
The Exercise Price (“Exercise Price”) shall initially equal $0.50 per share, subject to adjustment pursuant to the
terms hereof, including but not limited to Section 5 below. Payment of the Exercise Price may be made by either of the following,
or combination thereof, at the election of Holder:

 

(i) Cash Exercise: The Holder may exercise
this Warrant in cash, bank or cashier’s check or wire transfer; or

 

(ii) Cashless Exercise:
The Holder may exercise this Warrant in a cashless exercise transaction. In order to effect a Cashless Exercise, the Holder shall
surrender this Warrant at the principal office of the Company together with the Exercise Form attached hereto as Exhibit A indicating
that the Holder is exercising the Warrant pursuant to a cashless election, in which event the Company shall issue Holder a number
of shares of Common Stock computed using the following formula (a “Cashless Exercise”):

 

X = Y (A-B)/A

 

where:    X = the number of shares of
Common Stock to be issued to Holder.

 

Y = the number of shares of Common Stock for which
this Warrant is being Exercised.

 

A = the Market Price of one (1) share of Common Stock
(for purposes of this Section 3(a)(ii), where “Market Price,” as of any date, means the Closing Price (as defined
herein) of the Company’s Common Stock during the most recent Trading Day. B = the Exercise Price.

 

As
used herein, the “Closing Price” for any security as of any date means the sale price on The NASDAQ Global Market
(“NASDAQ”) as reported by, or based upon data reported by, Bloomberg Financial Markets or an equivalent, reliable
reporting service mutually acceptable to and hereafter designated by holders of a majority in interest of the Warrants and the
Company (“Bloomberg”) or, if NASDAQ is not the principal trading market for such security, the sale price of such
security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg,
or, if no sale price is reported for such security, then the last closing trade price of such security as reported by Bloomberg,
or, if no last closing trade price is reported for such security by Bloomberg, the average of the bid prices of any market makers
for such security that are listed in the over the counter market by the Financial Industry Regulatory Authority, Inc. or in the
“pink sheets” by the Pink OTC Market, Inc, or in the Over-The-Counter Bulletin Board (“OTCBB”). If the
Closing Price cannot be calculated for such security on such date in the manner provided above, the price shall be the fair market
value as mutually determined by the Company and the Holders of a majority in interest of the Warrants being Exercised for which
the calculation of the price is required in order to determine the Exercise Price of such Warrants. “Trading Day”
shall mean any day on which the Common Stock is traded for any period on the OTCBB, NASDAQ, or on the principal securities exchange
or other securities market on which the Common Stock is then being traded.

 

    	 

    	 

    

 

For purposes of Rule 144 and sub-section
(d)(3)(ii) thereof, it is intended, understood and acknowledged that the Common Stock issuable upon Exercise of this Warrant in
a Cashless Exercise transaction shall be deemed to have been acquired at the time this Warrant was issued. Moreover, it is intended,
understood and acknowledged that the holding period for the Common Stock issuable upon Exercise of this Warrant in a Cashless Exercise
transaction shall be deemed to have commenced on the date this Warrant was issued.

 

(b)
Cashless Major Exercise: To the extent the Holder shall exercise this Warrant or any portion thereof as a Cashless Major Exercise
pursuant to Section 5(c)(i) below, the Holder shall surrender this Warrant at the principal office of the Company together with
the Exercise Form indicating that the Holder is exercising this Warrant (or such portion thereof) pursuant to a Cashless Major
Exercise, in which event the Company shall issue a number of shares of Common Stock equal to the Black-Scholes Value (as defined
in Section 5(c)(iii) below) of the remaining unexercised portion of this Warrant (or such applicable portion being exercised)
divided by the closing price of the Common Stock on the principal securities exchange or other securities market on which the
Common Stock is then traded on the Trading Day immediately preceding the date on which the applicable Major Transaction is consummated
(such number of shares, the “Black Scholes Shares Amount”).

 

(c)
Dispute Resolution. In the case of a dispute as to the determination of the closing price or the Volume Weighted Average
Price of the Company’s Common Stock or the arithmetic calculation of the Exercise Price, Market Price or any Major Transaction
Warrant Early Termination Price, the Company shall submit the disputed determinations or arithmetic calculations via facsimile
within two (2) business days of receipt, or deemed receipt, of the Exercise Notice or Major Transaction Early Termination Notice,
or other event giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree
upon such determination or calculation within two (2) business days of such disputed determination or arithmetic calculation being
submitted to the Holder, then the Company shall, within two (2) business days submit via facsimile (i) the disputed determination
of the closing price or the Volume Weighted Average Price of the Company’s Common Stock to an independent, reputable investment
bank selected by the Company and approved by the Holder, which approval shall not be unreasonably withheld or (ii) the disputed
arithmetic calculation of the Exercise Price, Market Price or any Major Transaction Warrant Early Termination Price to the Company’s
independent, outside accountant. The Company shall cause the investment bank or the accountant, as the case may be, to perform
the determinations or calculations and notify the Company and the Holder of the results no later than five (5) business days from
the time such investment bank or accountant, as the case may be, receives the disputed determinations or calculations. Such investment
bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent
demonstrable error.

 

4. Transfer Rights.
Subject to the provisions of Section 8 of this Warrant, this Warrant may be transferred on the books of the Company, in whole
or in part, in person or by attorney, upon surrender of this Warrant properly completed and endorsed. This Warrant shall be canceled
upon such surrender and, as soon as practicable thereafter, the person to whom such transfer is made shall be entitled to receive
a new Warrant or Warrants as to the portion of this Warrant transferred, and Holder shall be entitled to receive a new Warrant
as to the portion hereof retained.

 

5. Adjustments Upon
Certain Events.

 

(a) Participation.
The Holder, as the holder of this Warrant, shall be entitled to receive such dividends paid and distributions of any kind made
to the holders of Common Stock of the Company to the same extent as if the Holder had Exercised this Warrant into Common Stock
(without regard to any limitations on exercise herein or elsewhere and without regard to whether or not a sufficient number of
shares are authorized and reserved to effect any such exercise and issuance) and had held such shares of Common Stock on the record
date for such dividends and distributions. Payments under the preceding sentence shall be made concurrently with the dividend or
distribution to the holders of Common Stock.

 

(b) Recapitalization
or Reclassification. If the Company shall at any time effect a stock split, payment of stock dividend, recapitalization, reclassification
or other similar transaction of such character that the shares of Common Stock shall be changed into or become exchangeable for
a larger or smaller number of shares, then upon the effective date thereof, the number of shares of Common Stock which Holder shall
be entitled to purchase upon Exercise of this Warrant shall be increased or decreased, as the case may be, in direct proportion
to the increase or decrease in the number of shares of Common Stock by reason of such stock split, payment of stock dividend, recapitalization,
reclassification or similar transaction, and the Exercise Price shall be, in the case of an increase in the number of shares, proportionally
decreased and, in the case of decrease in the number of shares, proportionally increased. The Company shall give Holder the same
notice it provides to holders of Common Stock of any transaction described in this Section 5(b).

 

    	 

    	 

    

 

(c) Rights Upon Major
Transaction.

 

(i)
Major Transaction. In the event that a Major Transaction (as defined below) occurs, then (1) in the case of a Cash-Out
Major Transaction and in the case of a Mixed Major Transaction to the extent of the percentage of the cash consideration in the
Mixed Major Transaction (determined in accordance with the definition of a Mixed Major Transaction below), the Holder, at its
option, may require the Company to redeem the Holder’s outstanding Warrants in accordance with Section 5(c)(iii) below,
(2) in the case of a transaction with a Publicly Traded Successor Entity covered by the provisions of Section 5(c)(i)(A) below
in which the Company is not the surviving entity (a “Successor Redemption Transaction”) and in the case of a Mixed
Major Transaction that is a Successor Redemption Transaction, to the extent of the percentage of the consideration represented
by securities of a Publicly Traded Successor Entity, the Holder may require this Warrant to be treated as a Successor Redemption
in accordance with Section 5(c)(iii) below and (3) in the case of all other Major Transactions and in the case of a Mixed Major
Transaction that is not covered by clause 5(c)(i)(2), to the extent of the percentage of the consideration represented by securities
of a Successor Entity in the Mixed Major Transaction, the Holder shall have the right to exercise this Warrant as a Cashless Major
Exercise. In the event the Holder shall not have exercised any of its rights under clauses (1), (2) or (3) above within the applicable
time periods set forth herein, then the Major Transaction shall be treated as an Assumption (as defined below) in accordance with
Section 5(c)(ii) below unless the Holder waives its rights under this Section 5(c) with respect to such Major Transaction.

 

(A) a consolidation,
merger, exchange of shares, recapitalization, reorganization, business combination or other similar event, (1) following which
the holders of Common Stock immediately preceding such consolidation, merger, exchange, recapitalization, reorganization, combination
or event either (a) no longer hold a majority of the shares of Common Stock or (b) no longer have the ability to elect
a majority of the board of directors of the Company or (2) as a result of which shares of Common Stock shall be changed into
(or the shares of Common Stock become entitled to receive) the same or a different number of shares of the same or another class
or classes of stock or securities of another entity (collectively, a “Change of Control Transaction”);

 

(B) the sale or transfer,
in one transaction or in a series of related transactions, of significant assets of the Company which, without limitation, shall
include, but not be limited to, a sale or transfer, in one transaction or in a series of related transactions, of more than 50%
of the Company’s assets as reflected on its then latest publicly filed balance sheet (including proprietary rights), provided,
however, that except for a sale of all or substantially all of the Company’s assets, a collaborative arrangement, licensing
agreement, joint venture or partnership or similar business arrangement providing for the development or commercial exploitation
or, or right to develop or commercially exploit, the technology, intellectual property or products of the Company (including arrangements
that involve the assignment or licensing of any existing or newly developed intellectual property under such arrangements) whereby
income or profits are to be shared (including by lump sum royalty or running royalty) with any other entity shall not constitute
a Major Transaction;

 

(C) a purchase, tender
or exchange offer made to the holders of outstanding shares of Common Stock, such that following such purchase, tender or exchange
offer a Change of Control Transaction shall have occurred;

 

(D) the liquidation,
bankruptcy, insolvency, dissolution or winding-up (or the occurrence of any analogous proceeding) affecting the Company; or

 

(E) the shares of Common
Stock cease to be listed, traded or publicly quoted on the OTCBB, and are not promptly re-listed or requoted on either the New
York Stock Exchange, the NYSE Alternext U.S., the NASDAQ Global Select Market, the NASDAQ Capital Market or listed in the over
the counter market by the Financial Industry Regulatory Authority, Inc. or in the “pink sheets” by the Pink OTC Market,
Inc.

 

    	 

    	 

    

 

(ii) Assumption.
The Company shall not enter into or be party to a Major Transaction that is to be treated as an Assumption pursuant to Section
5(c)(i), unless (i) any Person purchasing the Company’s assets or Common Stock, or any successor entity resulting from such
Major Transaction (in each case, a “Successor Entity”), assumes in writing all of the obligations of the Company under
this Warrant, and (ii) pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder
prior to such Major Transaction, including agreements to deliver to each holder of Warrants in exchange for such Warrants a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Warrants, including,
without limitation, an instrument representing the appropriate number of shares of the Successor Entity, having similar exercise
rights as the Warrants (including but not limited to a similar Exercise Price and similar Exercise Price adjustment provisions
based on the price per share or conversion ratio to be received by the holders of Common Stock in the Major Transaction), satisfactory
to the Holder. Upon the occurrence of any Major Transaction, any Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Major Transaction, the provisions of this Warrant referring to the “Company” shall
refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation
of the Major Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise
or redemption of this Warrant at any time after the consummation of the Major Transaction, in lieu of the shares of Common Stock
(or other securities, cash, assets or other property) issuable upon the exercise of the Warrants prior to such Major Transaction,
such shares of common stock (or their equivalent) of the Successor Entity, as adjusted in accordance with the provisions of this
Warrant. The provisions of this Section shall apply similarly and equally to successive Major Transactions and shall be applied
without regard to any limitations on the exercise of this Warrant other than any applicable beneficial ownership limitations. Any
assumption of Company obligations under this paragraph shall be referred to herein as an “Assumption.”

 

(iii) Notice; Major
Transaction Early Termination Right; Notice of Cashless Major Exercise. At least thirty (30) days prior to the consummation
of any Major Transaction, but, in any event, on the first to occur of (x) the date of the public announcement of such Major
Transaction if such announcement is made before 4:00 p.m., New York City time, or (y) the day following the public announcement
of such Major Transaction if such announcement is made on and after 4:00 p.m., New York City time, the Company shall deliver written
notice thereof via facsimile and overnight courier to the Holder (a “Major Transaction Notice”). At any time during
the period beginning after the Holder’s receipt of a Major Transaction Notice and ending five (5) Trading Days prior to the
consummation of such Major Transaction (the “Early Termination Period”), the Holder may require the Company to redeem
(an “Early Termination Upon Major Transaction”) all or any portion of this Warrant not eligible to be treated as a
Cashless Major Exercise (without taking into consideration the 9.98% Cap) by delivering written notice thereof (“Major Transaction
Early Termination Notice”) to the Company, which Major Transaction Early Termination Notice shall indicate the portion of
the principal amount (the “Early Termination Principal Amount”) of the Warrant that the Holder is electing to have
redeemed. The portion of this Warrant subject to early termination pursuant to this Section 5(c)(iii) (the “Redeemable
Shares”), shall be redeemed by the Company at a price (the “Major Transaction Warrant Early Termination Price”)
payable in cash equal to the Black Scholes Value of the Redeemable Shares determined by use of the Black Scholes Option Pricing
Model using the criteria set forth in Schedule 1 hereto (the “Black Scholes Value”).

 

At any time during the
Early Termination Period, the Holder may require the Company to treat all or any portion of this Warrant eligible to be treated
as a Successor Redemption (without taking into consideration the 9.98% Cap) as a Successor Redemption by delivering written notice
thereof (a “Successor Redemption Notice”) to the Company, which Successor Redemption Notice shall indicate the portion
of the principal amount of the Warrant that the Holder is electing to have treated as a Successor Redemption. The portion of this
Warrant subject to Successor redemption pursuant to this Section 5(c)(iii) (the “Successor Redemption Shares”), shall
be converted upon consummation of such Major Transaction into the number of securities of the Successor Entity (the “Successor
Redemption Shares”) that would be issuable under the terms of such Major Transaction in respect of a number of shares of
Common Stock equal to the Black Scholes Share Amount.

 

    	 

    	 

    

 

To
the extent the Holder shall elect to effect a Cashless Major Exercise in respect of a Major Transaction, the Holder shall deliver
its exercise notice in accordance with Section 3(b), within the Early Termination Period.

 

(iv)
Escrow; Payment of Major Transaction Warrant Early Termination Price. Following the receipt of a Major Transaction Early
Termination Notice or a Cashless Major Exercise from the Holder, the Company shall not effect a Major Transaction that is being
treated as an early termination or is eligible to be treated as a Cashless Major Exercise unless (a) the definitive documentation
governing such Major Transaction provides that it shall be a condition precedent to the consummation of such Major Transaction
that the Holder be issued or paid, as the case may be, an amount in shares of Common Stock or cash, as applicable, equal to the
Major Transaction Warrant Early Termination Price and/or applicable Exercise Shares or (b) it shall first place into an escrow
account with an independent escrow agent, at least three (3) business days prior to the closing date of the Major Transaction
(the “Major Transaction Escrow Deadline”), an amount in shares of Common Stock (or irrevocable instructions to the
Transfer Agent to issue such shares) or cash, as applicable, equal to the Major Transaction Warrant Early Termination Price and/or
applicable Exercise Shares. Concurrently upon closing of such Major Transaction, the Company shall pay or shall instruct the escrow
agent to pay the Major Transaction Warrant Early Termination Price and/or to deliver the applicable Exercise Shares to the Holder.
For purposes of determining the amount required to be placed in escrow pursuant to the provisions of this subsection (iv) and
without affecting the amount of the actual Major Transaction Warrant Early Termination Price and/or applicable Exercise Shares,
the calculation of the price referred to in clause (1) of the first column of Schedule 1 hereto with respect to Stock
Price shall be determined based on the Closing Market Price (as defined on Schedule I) of the Common Stock on the Trading
Day immediately preceding the date that the funds and/or applicable Exercise Shares, as applicable, are deposited with the escrow
agent.

 

Following the
receipt of a Successor Redemption Notice, the Company shall not effect the applicable Major Transaction unless the definitive
documentation governing such Major Transaction includes an obligation by the Successor Entity to issue the Successor Redemption
Shares to the Holder upon consummation of the Major Transaction and designates the Holder as an express third party beneficiary
of such obligation.

 

(v)
Injunction. Following the receipt of a Major Transaction Early Termination Notice or notice of a Cashless Major Exercise
from the Holder, in the event that the Company attempts to consummate a Major Transaction without either placing the Major Transaction
Warrant Early Termination Price or applicable Exercise Shares, as applicable, in escrow in accordance with subsection (iv) above
or without payment of the Major Transaction Warrant Early Termination Price or issuance of the applicable Exercise Shares, as
applicable, to the Holder prior to consummation of such Major Transaction, or without providing for the issuance of Successor
Redemption Shares in accordance with Section 5(c) above, as applicable, the Holder shall have the right to apply for an injunction
in any state or federal courts sitting in the City of New York, borough of Manhattan to prevent the closing of such Major Transaction
until the Major Transaction Warrant Early Termination Price is paid to the Holder, in full, the applicable Exercise Shares are
delivered or the issuance of the Successor Redemption Shares is provided for, as applicable.

 

An early termination
required by this Section 5(c) shall be made in accordance with the provisions of Section 12 and shall have priority
to payments to holders of Common Stock in connection with a Major Transaction to the extent an early termination required by this
Section 5(c)(iii) are deemed or determined by a court of competent jurisdiction to be prepayments of the Warrant by the Company,
such early termination shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this Section 5,
until the Major Transaction Warrant Early Termination Price is paid in full or the Successor Redemption Shares are fully issued,
as applicable, this Warrant may be exercised, in whole or in part, by the Holder into shares of Common Stock, or in the event
the Exercise Date is after the consummation of the Major Transaction or in the event of a Successor Redemption, shares of publicly
traded common stock (or their equivalent) of the Successor Entity pursuant to Section 5(c). The parties hereto agree that in the
event of the Company’s early termination of any portion of the Warrant under this Section 5(c), the Holder’s
damages would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates
and the uncertainty of the availability of a suitable substitute investment opportunity for the Holder. Accordingly, any premium
due under this Section 5(c) is intended by the parties to be, and shall be deemed, a reasonable estimate of the Holder’s
actual loss of its investment opportunity and not as a penalty.

 

    	 

    	 

    

 

For purposes
hereof:

 

“Cash-Out
Major Transaction” means a Major Transaction in which the consideration payable to holders of Common Stock in connection
with the Major Transaction consists solely of cash.

 

“Cashless
Major Exercise” shall mean an exercise of this Warrant or portion thereof as a “Cashless Major Exercise” in
accordance with Section 3(b) and 5(c)(i) hereof.

 

“Eligible
Market” means the OTCBB, the New York Stock Exchange, Inc., the NYSE Arca, the NASDAQ Capital Market, the NASDAQ Global
Market, the NASDAQ Global Select Market or the NYSE Alternext U.S.

 

“Mixed
Major Transaction” means a Major Transaction in which the consideration payable to the shareholders of the Company consists
partially of cash and partially of securities of a Successor Entity. If the Successor Entity is a Publicly Traded Successor Entity,
the percentage of consideration represented by securities of such Successor Entity shall be equal to the percentage that the value
of the aggregate anticipated number of shares of the Publicly Traded Successor Entity to be issued to holders of Common Stock
of the Company represents in comparison to the aggregate value of all consideration, including cash consideration, in such Mixed
Major Transaction, as such values are set forth in any definitive agreement for the Mixed Major Transaction that has been executed
at the time of the first public announcement of the Major Transaction or, if no such value is determinable from such definitive
agreement, based on the closing market price for shares of the Publicly Traded Successor Entity on its principal securities exchange
on the Trading Day preceding the first public announcement of the Mixed Major Transaction. If the Successor Entity is a Private
Successor Entity, the percentage of consideration represented by securities of such Successor Entity shall be determined in good-faith
by the Company's Board of Directors

 

“Parent
Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock
or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity,
the Person or Parent Entity with the largest public market capitalization as of the date of consummation of a Major Transaction.

 

“Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

 

“Private
Successor Entity” means a Successor Entity that is not a Publicly Traded Successor Entity.

 

“Publicly
Traded Successor Entity” means a Successor Entity that is a publicly traded corporation whose common stock is quoted on
or listed for trading on an Eligible Market (as defined above).

 

“Successor
Entity” means any Person purchasing the Company’s assets or Common Stock, or any successor entity resulting from such
Major Transaction, or if the Warrant is to be exercisable for shares of capital stock of its Parent Entity (as defined above),
its Parent Entity.

 

(d)
Exercise Price Adjusted. As used in this Warrant, the term “Exercise Price” shall mean the purchase price per
share specified in Section 3(a) of this Warrant, until the occurrence of an event stated in this Section 5 or otherwise
set forth in this Warrant, and thereafter shall mean said price as adjusted from time to time in accordance with the provisions
of said subsection. No adjustment made pursuant to any provision of this Section 5 shall have the net effect of increasing
the aggregate Exercise Price in relation to the split adjusted and distribution adjusted price of the Common Stock.

 

(e)
Adjustments: Additional Shares, Securities or Assets. In the event that at any time, as a result of an adjustment made pursuant
to this Section 5 or otherwise, Holder shall, upon Exercise of this Warrant, become entitled to receive shares and/or other
securities or assets (other than Common Stock) then, wherever appropriate, all references herein to shares of Common Stock shall
be deemed to refer to and include such shares and/or other securities or assets; and thereafter the number of such shares and/or
other securities or assets shall be subject to adjustment from time to time in a manner and upon terms as nearly equivalent as
practicable to the provisions of this Section 5.

 

(f)
Notice of Adjustments. Whenever the Exercise Price is adjusted pursuant to the terms of this Warrant, the Company shall promptly
mail to the Holder a notice (an “Exercise Price Adjustment Notice”) setting forth the Exercise Price after such adjustment
and setting forth a statement of the facts requiring such adjustment. The Company shall, upon the written request at any time
of the Holder, furnish to such Holder a like Warrant setting forth (i) such adjustment or readjustment, (ii) the Exercise
Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or
property which at the time would be received upon Exercise of the Warrant. For purposes of clarification, whether or not the Company
provides an Exercise Price Adjustment Notice pursuant to this Section 5(f), upon the occurrence of any event that leads to
an adjustment of the Exercise Price, the Holder would be entitled to receive a number of Exercise Shares based upon the new Exercise
Price, as adjusted, for exercises occurring on or after the date of such adjustment, regardless of whether the Holder accurately
refers to the adjusted Exercise Price in the Exercise Form.

 

    	 

    	 

    

 

6.
Fractional Interests.

 

No fractional
shares or scrip representing fractional shares shall be issuable upon the Exercise of this Warrant, but on Exercise of this Warrant,
Holder may purchase only a whole number of shares of Common Stock. If, on Exercise of this Warrant, Holder would be entitled to
a fractional share of Common Stock or a right to acquire a fractional share of Common Stock, such fractional share shall be disregarded
and the number of shares of Common Stock issuable upon Exercise shall be the next higher whole number of shares.

 

7.
Reservation of Shares.

 

From and after
the date hereof, the Company shall at all times reserve for issuance such number of authorized and unissued shares of Common Stock
(or other securities substituted therefor as herein above provided) as shall be sufficient for the Exercise of this Warrant and
payment of the Exercise Price. If at any time the number of shares of Common Stock authorized and reserved for issuance is below
the number of shares sufficient for the Exercise of this Warrant (a “Share Authorization Failure”) (based on the Exercise
Price in effect from time to time), the Company will promptly take all corporate action necessary to authorize and reserve a sufficient
number of shares, including, without limitation, calling a special meeting of stockholders to authorize additional shares to meet
the Company’s obligations under this Section 7, in the case of an insufficient number of authorized shares, and using
its best efforts to obtain stockholder approval of an increase in such authorized number of shares. The Company covenants and
agrees that upon the Exercise of this Warrant, all shares of Common Stock issuable upon such Exercise shall be duly and validly
issued, fully paid and nonassessable and not subject to preemptive rights, rights of first refusal or similar rights of any Person.

 

8.
Restrictions on Transfer.

 

(a)
Registration or Exemption Required. This Warrant has been issued in a transaction exempt from the registration requirements
of the Securities Act by virtue of Regulation D and exempt from state registration or qualification under applicable state laws.
None of the Warrant or the Exercise Shares may be pledged, transferred, sold, assigned, hypothecated or otherwise disposed of
except pursuant to an effective registration statement or an exemption to the registration requirements of the Securities Act
and applicable state laws including, without limitation, a so-called “4(1) and a half” transaction.

 

(b)
Assignment. Should the Holder desire to sell, transfer, assign, pledge, hypothecate or otherwise dispose of this Warrant,
in whole or in part; the Holder shall deliver a written notice to Company, substantially in the form of the Assignment attached
hereto as Exhibit B, indicating the Person or Persons to whom the Warrant is requested to be assigned and the respective
number of Warrant Shares to be assigned to each assignee. The Company may permit the assignment upon such reasonable conditions
as the Company may require, including the delivery to the Company of an acceptable opinion of counsel as to the assignment’s
qualification for an exemption from registration. This Warrant and the rights evidenced hereby shall inure to the benefit of and
be binding upon the successors and permitted assigns of the Holder.

 

(c)
Representations of the Holder. The right to acquire Common Stock or the Common Stock issuable upon exercise of the Holder’s
rights contained herein will be acquired for investment and not with a view to the sale or distribution of any part thereof, and
the Holder has no present intention of selling, transferring, assigning, pledging, hypothecating or otherwise disposing of this
Warrant in any public distribution of the same except pursuant to a registration or exemption. Holder is an “accredited
investor” within the meaning of the Securities and Exchange Commission’s Rule 501 of Regulation D, as presently in
effect. The Holder understands (i) that the Common Stock issuable upon exercise of the Holder’s rights contained herein
is not registered under the Securities Act or qualified under applicable state securities laws on the ground that the issuance
contemplated by this Warrant will be exempt from the registration and qualifications requirements thereof and (ii) that the Company’s
reliance on such exemption is predicated on the representations set forth in this Section 8(c). The Holder has such knowledge
and experience in financial and business matters as to be capable of evaluating the merits and risks of its investment and has
the ability to bear the economic risks of its investment.

 

    	 

    	 

    

 

9.
Noncircumvention.

 

The Company
hereby covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any
reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will
at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the
rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value
of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, and (ii) shall
take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and
nonassessable shares of Common Stock upon the exercise of this Warrant.

 

10.
Benefits of this Warrant.

 

Nothing in
this Warrant shall be construed to confer upon any person other than the Company and Holder any legal or equitable right, remedy
or claim under this Warrant and this Warrant shall be for the sole and exclusive benefit of the Company and Holder.

 

11.
Governing Law.

 

All questions
concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and
enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of law
thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) shall be commenced exclusively in the state and federal courts sitting in Los Angeles, California. Each party
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in such city for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to
such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any other manner permitted by law. The parties hereby waive all rights to a trial by jury. If either party shall
commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding
shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding.

 

12.
Loss of Warrant.

 

Upon receipt
by the Company of evidence of the loss, theft, destruction or mutilation of this Warrant, and (in the case of loss, theft or destruction)
of indemnity or security reasonably satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated,
the Company shall execute and deliver a new Warrant of like tenor and date.

 

    	 

    	 

    

 

13.
Notice or Demands.

 

Notices or
demands pursuant to this Warrant to be given or made by Holder to or on the Company shall be sufficiently given or made if sent
by certified or registered mail, return receipt requested, postage prepaid, and addressed, until another address is designated
in writing by the Company, to the address set forth in Section 2(a) above. Notices or demands pursuant to this Warrant to
be given or made by the Company to or on Holder shall be sufficiently given or made if sent by certified or registered mail, return
receipt requested, postage prepaid, and addressed, to the address of Holder set forth in the Company’s records, until another
address is designated in writing by Holder.

 

IN WITNESS
WHEREOF, the undersigned has executed this Warrant as of the _____ day of ______, 2014.

 

	 	CRYOPORT, INC.
	 	 	 
	 	By:  	 
	 	 	Title:

  

    	 

    	 

    

 

EXHIBIT A

 

EXERCISE FORM
FOR WARRANT

 

TO: [                                           ]

 

CHECK
THE APPLICABLE BOX:

 

	 ̈	Exercise

                            

        The
        undersigned hereby irrevocably exercises the attached warrant (the “Warrant”) with respect to shares of Common
        Stock (the “Common Stock”) of Cryoport, Inc., a Nevada corporation (the “Company”), and, if pursuant
        to a Cashless Exercise, herewith makes payment of the Exercise Price with respect to such shares in full, all in accordance
        with the conditions and provisions of said Warrant.

         

        [IF
        APPLICABLE: The undersigned hereby encloses $____ as payment of the Exercise Price.]

	 	 
	 ̈	Cashless
                                         Major Exercise

         

        The
        undersigned hereby irrevocably exercises the Warrant with respect to ____% of the Warrant currently outstanding pursuant
        to a Cashless Major Exercise in accordance with the terms of the Warrant.

 

 

1. The undersigned
requests that any stock certificates for such shares be issued and, if applicable, a warrant representing any unexercised portion
hereof be issued, pursuant to the Warrant in the name of the undersigned and delivered to the undersigned at the address set forth
below.

 

2. Capitalized
terms used but not otherwise defined in this Exercise Form shall have the meaning ascribed thereto in the Warrant.

 

Dated: _______________

 

	 
	Signature
	 
	 
	Print Name
	 
	 
	Address

 

NOTICE

 

The signature to the foregoing Exercise
Form must correspond to the name as written upon the face of the attached Warrant in every particular, without alteration or enlargement
or any change whatsoever.

 

    	 

    	 

    

 

EXHIBIT B

 

ASSIGNMENT

 

(To be executed
by the registered holder

desiring to transfer the Warrant)

 

FOR VALUE RECEIVED, the undersigned
holder of the attached warrant (the “Warrant”) hereby sells, assigns and transfers unto the person or persons below
named the right to purchase __________ shares of the Common Stock of Cryoport, Inc., a Nevada corporation, evidenced by the attached
Warrant and does hereby irrevocably constitute and appoint __________ attorney to transfer the said Warrant on the books of the
Company, with full power of substitution in the premises.

 

	Dated: _______________	 	 
	 	 	Signature

 

Fill in for new registration of
Warrant:

 

	 	 
	Name	 
	 	 
	 	 
	Address	 
	 	 
	 	 
	Please print name and address of assignee	 
	(including zip code number)	 

 

NOTICE

 

The signature to the foregoing Assignment
must correspond to the name as written upon the face of the attached Warrant in every particular, without alteration or enlargement
or any change whatsoever.

  

    	 

    	 

    

 

Schedule 1

 

Black-Scholes
Value

 

Calculation
Under Section 5(c)(iii)

 

	Remaining
    Term	Number
    of calendar days from date of public announcement of the Major Transaction after commencement of the Exercise Period until
    the last date on which the Warrant may be exercised.
	 	 
	Interest
    Rate	A
    risk-free interest rate corresponding to the US$ LIBOR/Swap rate for a period equal to the Remaining Term.
	 	 
	Volatility	If the first public announcement
        of the Major

        Transaction is made at or
        prior to 4:00 p.m., New

        York City time, the arithmetic
        mean of the historical

        volatility for the 10, 30
        and 50 Trading Day periods

        ending on the date of such
        first public

        announcement, obtained from
        the HVT or similar

        function on Bloomberg.

        

        If the first public announcement
        of the Major

        Transaction is made after
        4:00 p.m., New York City

        time, the arithmetic mean
        of the historical volatility for the

        10, 30 and 50 Trading Day
        periods ending on the

        next succeeding Trading
        Day following the date of

        such first public announcement,
        obtained from the

        HVT or similar function
        on Bloomberg.

         

	Stock
    Price	The
    greater of (1) the closing price of the Common Stock on the OTCBB, or, if that is not the principal trading market for
    the Common Stock, such principal market on which the Common Stock is traded or listed (the “Closing Market Price”)
    on the trading day immediately preceding the date on which a Major Transaction is consummated, (2) the first Closing
    Market Price following the first public announcement of a Major Transaction, or (3) the Closing Market Price as of the
    date immediately preceding the first public announcement of the Major Transaction.
	 	 
	Dividends	Zero.
	 	 
	Strike
    Price	Exercise
    Price as defined in section 3(a).Exhibit 10.1

 

 

IMPORTANT: PLEASE READ CAREFULLY
BEFORE SIGNING

SIGNIFICANT REPRESENTATIONS ARE CALLED
FOR HEREIN

 

 

SUBSCRIPTION AGREEMENT AND LETTER
OF INVESTMENT INTENT

 

The undersigned hereby
tenders this subscription and applies for the purchase of the amount of the principal sum of a 2014 Series Secured Promissory Note
as indicated on the signature page herein and the warrants (“the Securities”), of Cryoport, Inc. (the “Company”),
upon the terms and conditions set forth below.

 

Subscription payment is by:

 

	_____	A check in the amount of the Note being subscribed payable to either “Cryoport, Inc.” or “Cryoport Systems, Inc.”  
	 	 
	_____	A wire transfer in the amount of the subscription sent to:

 

 

	Comerica Bank	 
	ABA/Routing #:	121137522
	Account Number:	1894559580
	Account Name:	Cryoport Systems Inc.

 

The undersigned understands
that the Company has the right to reject any subscription for the Securities for any reason and that the Company will cause to
be returned the funds delivered herewith if this subscription is rejected. By execution below, the undersigned acknowledges that
the Company is relying upon the accuracy and completeness of the representations contained herein in complying with its obligations
under applicable securities laws.

 

		1.	Subscriber’s Representations. The undersigned acknowledges and represents as follows:

 

		(a)	That the undersigned is familiar with the publicly available filings by the Company with the Securities
Exchange Commission and has received, and is familiar with, the Company’s Term Sheet dated November 26, 2014, which included
the form of the 2014 Series Secured Promissory Note, Warrant, and the Security Agreement (collectively the “Disclosure
Documents”);

 

		(b)	That the undersigned is in a financial position to hold the Securities for an indefinite period
of time and is able to bear the economic risk and withstand a complete loss of its investment in the Securities;

 

    	 

    	 

    

 

		(c)	That the undersigned believes it, either alone or with the assistance of its professional advisor,
has such knowledge and experience in financial and business matters that it is capable of reading and interpreting the Disclosure
Documents and evaluating the merits and risks of the prospective investment in the Securities and has the net worth to undertake
such risks;

 

		(d)	That the undersigned has obtained, to the extent it deems necessary, professional advice with respect
to the risks inherent in the investment in the Securities, and the suitability of the investment in the Securities in light of
its financial condition and investment needs;

 

		(e)	That the undersigned believes that the investment in the Securities is suitable for it based upon
its investment objectives and financial needs, and the undersigned has adequate means for providing for its current financial needs
and contingencies and has no need for liquidity of investment with respect to the Securities;

 

		(f)	That the undersigned understands that the Administrative Agent under the Security Agreement may
not act in manners the undersigned deems to be necessary to protect the interests of the undersigned;

 

		(g)	That the undersigned recognizes that an investment in the Securities involves a high degree of
risk;

 

		(h)	That the undersigned realizes that (1) the purchase of the Securities is a long-term investment,
(2) the purchaser of the Securities must bear the economic risk of investment for an indefinite period of time because the Securities
and any such shares issued on exercise of the Warrant issued to the undersigned will not have been registered under the Securities
Act of 1933 and, therefore, cannot be sold unless they are subsequently registered under said Act or an exemption from such registration
is available and (3) the transferability of the Securities and such shares is restricted pending effectiveness of such a registration
of qualification for an exemption;

 

		(i)	That the undersigned has been advised that the offering and issuance of the Securities will not
be registered under the Securities Act of 1933 or the relevant state securities laws but are being offered and issued pursuant
to exemptions from such laws and that the Company’s reliance upon such exemptions is predicated in part on the undersigned’s
representations as contained herein. The undersigned represents and warrants that the Securities are being purchased for the undersigned’s
own account and for investment and without the intention of reselling or redistributing the same, that it has made no agreement
with others regarding any of such Securities and that its financial condition is such that it is not likely that it will be necessary
to dispose of any of the Securities in the foreseeable future;

 

		(j)	That the undersigned is a bona fide resident of, and is domiciled in the state indicated on the
signature page below under “Address”, and that the Securities are being purchased by it in its name solely for its
own beneficial interest and not as nominee for, or on behalf of, or for the beneficial interest of, or with the intention to transfer
to, any other person, trust or organization; and

 

    	2

    	 

    

 

		(k)	That the undersigned understands that the representations contained below are made for the purpose
of qualifying it is an “accredited investor” as that term is defined in Regulation D of the General Rules and Regulations
under the Securities Act of 1933 and for the purpose of inducing a sale of securities to it. The undersigned hereby represents
that the statement or statements initialled below are true and correct in all respects. The undersigned understands that a false
representation may constitute a violation of law, and that any person who suffers damage as a result of a false representation
may have a claim against the undersigned for damages.

 

		2.	Accredited Investor Status.

 

		(a)	Accredited individual investors must initial either or both of the following
two statements:

 

	_____ (1)	I certify that I am an accredited investor because I had individual income (exclusive of any income attributable to my spouse) of more than $200,000 in each of the most recent two years or joint income with my spouse of more than $300,000 in each of such years and I reasonably expect to have an individual income in excess of such amounts for the current year.
	 	 
	_____ (2)	I certify that I am an accredited investor because I have an individual net worth, or my spouse and I have a combined individual net worth, in excess of one million dollars. For purposes of this questionnaire, “net worth” excludes the equity in my or our primary residence.

 

		(b)	Accredited partnerships, corporations or other entities must initial one or more
of the following statements:

 

	______ (1)	The undersigned hereby certifies that all of the beneficial equity owners of the undersigned qualify as accredited individual investors under items (a)1 or (a)2 above. (Subscribers attempting to qualify under this item may be required to provide additional information beyond the equity owner of the Subscriber,
	 	 
	______ (2)	The undersigned is a bank or savings and loan association as defined in Sections 3(a)(2) and 3(a)(5)(A), respectively, of the Act acting either in its individual or fiduciary capacity.
	 	 
	______ (3)	The undersigned is an insurance company as defined in Section 2(13) of the Act.
	 	 
	______ (4)	The undersigned is an investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act.
	 	 
	______ (5)	This Agreement has been duly authorized by all necessary action on the part of the undersigned, has been duly executed by an authorized officer or representative of the undersigned, and is a legal, valid and binding obligation of the undersigned enforceable in accordance with its terms.

 

    	3

    	 

    

 

Principal Sum of 2014 Series Secured Promissory Note:
$ ______________

 

Manner in which title to the Secured Promissory Note and
Warrants are to be held (please initial one):

 

	_____ Individual 	_____ Joint tenants with Right of Survivorship 
	_____ Community Property 	_____ Tenants-in-Common 
	_____ Corporation	_____ Trust
	_____ IRA	_____ Qualified Retirement Plans
	_____ SEP/SIMPLE	_____ LLC
	_____ Partnership	____ Other

 

	 	IN WITNESS WHEREOF, the undersigned has executed this Subscription Agreement on this ________
___, 2014
	 	 	 
	 	 	 	 	 
	 	Signature	 	Signature
	 	 	 	 
	 	 	 	 

 

 

* * * * * * * *

 

    	4

    	 

    

 

PLEASE PRINT BELOW THE REGISTRATION

INFORMATION OF EACH SUBSCRIBER

 

	SUBSCRIBER (INDIVIDUAL and JOINT)	 	ENTITY
	(Please type or print name[s] exactly as it should appear on the Certificate)	 	(Please type or print name[s] exactly as it should appear on the Certificate)
	 	 	 
	 	 	 
	Name(s) Typed or Printed	 	Name Typed or Printed
	 	 	 
	 	 	 
	Daytime Phone	 	Business Phone
	 	 	 
	 	 	 
	Email Address	 	Email Address
	 	 	 
	 	 	 
	Address to Which Correspondence Should be Directed:	 	Address to Which Correspondence Should be Directed:
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	Name Person to Contact
	Social Security Number	 	 
	 	 	 
	 	 	Entity’s Taxpayer Identification Number

 

    	5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]